198 related articles for article (PubMed ID: 21436441)
1. Brothers in arms against cancer.
Leslie M
Science; 2011 Mar; 331(6024):1551-2. PubMed ID: 21436441
[No Abstract] [Full Text] [Related]
2. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
Vilgelm A; El-Rifai W; Zaika A
Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
[TBL] [Abstract][Full Text] [Related]
3. P53 family activities in development and cancer: relationship to melanocyte and keratinocyte carcinogenesis.
Johnson J; Lagowski J; Sundberg A; Kulesz-Martin M
J Invest Dermatol; 2005 Nov; 125(5):857-64. PubMed ID: 16297181
[No Abstract] [Full Text] [Related]
4. The role of p53 protein family in gastrointestinal malignancies.
Zaika AI; El-Rifai W
Cell Death Differ; 2006 Jun; 13(6):935-40. PubMed ID: 16557273
[No Abstract] [Full Text] [Related]
5. The functional domains in p53 family proteins exhibit both common and distinct properties.
Harms KL; Chen X
Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
[No Abstract] [Full Text] [Related]
6. p73: a complex gene for building a complex brain.
Meyer G
Cell Cycle; 2011 Apr; 10(8):1188-9. PubMed ID: 21441779
[No Abstract] [Full Text] [Related]
7. p73-mediated chemosensitivity: a preferential target of oncogenic mutant p53.
Strano S; Blandino G
Cell Cycle; 2003; 2(4):348-9. PubMed ID: 12851488
[No Abstract] [Full Text] [Related]
8. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
9. [The coordinated interaction of multifunctional members of p53 family determines many key processes in multicellular organisms].
Vilgelm AE; Zaika AI; Prasolov VS
Mol Biol (Mosk); 2011; 45(1):180-97. PubMed ID: 21485507
[TBL] [Abstract][Full Text] [Related]
10. p53 family members: similar biochemistry, different biology.
Barbieri CE; Pietenpol JA
Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
[No Abstract] [Full Text] [Related]
11. p53 Family isoforms.
Bourdon JC
Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
[TBL] [Abstract][Full Text] [Related]
12. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
13. Functional regulation of p73 and p63: development and cancer.
Melino G; Lu X; Gasco M; Crook T; Knight RA
Trends Biochem Sci; 2003 Dec; 28(12):663-70. PubMed ID: 14659698
[TBL] [Abstract][Full Text] [Related]
14. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
15. Targeting p73--a potential approach in cancer treatment.
Slade N; Horvat A
Curr Pharm Des; 2011; 17(6):591-602. PubMed ID: 21391909
[TBL] [Abstract][Full Text] [Related]
16. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
17. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
[TBL] [Abstract][Full Text] [Related]
18. The 5th International p63/p73 Workshop: much more than just tumour suppression.
Kadakia MP; Caron de Fromentel C; Sabapathy K
Cell Death Differ; 2012 Mar; 19(3):549-50. PubMed ID: 22240899
[No Abstract] [Full Text] [Related]
19. Another p53 Doppelgänger?
Kaelin WG
Science; 1998 Jul; 281(5373):57-8. PubMed ID: 9679018
[No Abstract] [Full Text] [Related]
20. Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.
Yao Y; Bellon M; Shelton SN; Nicot C
J Biol Chem; 2012 Jun; 287(24):20737-47. PubMed ID: 22496369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
